Cognition Therapeutics Inc.
Organization details
- Legal name
- Cognition Therapeutics Inc.
- Former names
- Cognition Theraputics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Purchase
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CGTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001455365
Board of directors
-
Aaron G.l. Fletcher · DirectorSince 2023
-
Brett P. Monia · DirectorSince 2023
-
Ellen B. Richstone · DirectorSince 2023
-
Jack A. Khattar · DirectorSince 2023
-
Leslie W. Kreis · DirectorSince 2023
-
Lisa Ricciardi · Director · CEO & PresidentSince 2023
-
Peggy Wallace · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.7%
-
95.7%
Board connections
5 of this board's directors also sit on 6 other boards. 5 are in the same sector.
-
Actuate Therapeutics Inc. Same sectorvia Aaron G.l. Fletcher and Leslie W. Kreis
-
Cue Biopharma Inc. Same sectorvia Aaron G.l. Fletcher
-
Indivior Pharmaceuticals Inc. Same sectorvia Jack A. Khattar
-
Ionis Pharmaceuticals Inc. Same sectorvia Brett P. Monia
- via Ellen B. Richstone
-
Supernus Pharmaceuticals Inc. Same sectorvia Jack A. Khattar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $32,493
- 3 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Jack A. Khattar Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Brett P. Monia Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Peggy Wallace Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Ellen B. Richstone Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | BIOS Memory SPV I, LP Director, 10% owner | Grant or award | +25,000 | — | — |
| May 1, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −8,567 | $1.28 | $10,966 |
| Apr 16, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Open-market purchase | +10,000 | $1.13 | $11,300 |
| Apr 16, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Open-market purchase | +9,175 | $1.10 | $10,093 |
| Apr 16, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Open-market purchase | +10,000 | $1.11 | $11,100 |
| Feb 15, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Shares withheld for tax | −5,850 | $1.12 | $6,552 |
| Feb 15, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −1,560 | $1.12 | $1,747 |
| Feb 15, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Shares withheld for tax | −4,680 | $1.12 | $5,242 |
| Feb 4, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −26,921 | $1.03 | $27,729 |
| Feb 4, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Shares withheld for tax | −51,704 | $1.03 | $53,255 |
| Feb 4, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Shares withheld for tax | −26,919 | $1.03 | $27,727 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cognition Therapeutics Inc.
Who is the CEO of Cognition Therapeutics Inc.?
Lisa Ricciardi is Cognition Therapeutics Inc.'s CEO & President.
How many directors are on Cognition Therapeutics Inc.'s board?
Cognition Therapeutics Inc.'s board has 7 directors: Aaron G.l. Fletcher, Brett P. Monia, Ellen B. Richstone, Jack A. Khattar, Leslie W. Kreis, Lisa Ricciardi and Peggy Wallace.
Are Cognition Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Cognition Therapeutics Inc. insiders bought $32,493 of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cognition-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.